fludarabine has been researched along with Adrenoleukodystrophy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, Y; Huang, XJ; Liu, KY; Qin, J; Wang, FR; Xu, LP; Yang, YL; Zhang, XH | 1 |
Bossuyt, X; Mariƫn, G; Uyttebroeck, A | 1 |
Horino, S; Matsuhashi, T; Minegishi, M; Niizuma, H; Onuma, M; Rikiishi, T; Sakamoto, O; Sasahara, Y; Tsuchiya, S; Uchiyama, T; Uematsu, M | 1 |
Abdul Hai, A; Ben-Harush, M; Bitan, M; Hershkovitz, E; Kapelushnik, J; Or, R; Resnick, IB; Schwartz, A; Shapira, MY; Slavin, S | 1 |
4 other study(ies) available for fludarabine and Adrenoleukodystrophy
Article | Year |
---|---|
Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.
Topics: Adrenoleukodystrophy; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mucopolysaccharidoses; Transplantation Conditioning; Transplantation, Haploidentical; Transplantation, Homologous; Vidarabine | 2018 |
A transient IgE monoclonal protein in a child.
Topics: Adrenoleukodystrophy; Antibodies, Monoclonal; Busulfan; Child; Cyclosporine; Epstein-Barr Virus Infections; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunoglobulin E; Immunosuppressive Agents; Vidarabine; Virus Activation | 2011 |
Successful cord blood transplantation with reduced-intensity conditioning for childhood cerebral X-linked adrenoleukodystrophy at advanced and early stages.
Topics: Adrenoleukodystrophy; Brain; Child; Cord Blood Stem Cell Transplantation; Humans; Male; Melphalan; Myeloablative Agonists; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2012 |
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Topics: Adrenoleukodystrophy; Busulfan; Child; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Magnetic Resonance Imaging; Male; Myeloablative Agonists; Transplantation Conditioning; Vidarabine | 2005 |